CARISMA Therapeutics Inc (CARM)
1.00
+0.02
(+1.52%)
USD |
NASDAQ |
Sep 27, 16:00
1.00
0.00 (0.00%)
After-Hours: 18:25
CARISMA Therapeutics Max Drawdown (5Y): 99.19% for Aug. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2024 | 99.19% |
| July 31, 2024 | 98.97% |
| June 30, 2024 | 98.97% |
| May 31, 2024 | 98.72% |
| April 30, 2024 | 98.34% |
| March 31, 2024 | 97.95% |
| February 29, 2024 | 97.95% |
| January 31, 2024 | 97.86% |
| December 31, 2023 | 97.59% |
| November 30, 2023 | 97.59% |
| October 31, 2023 | 97.20% |
| September 30, 2023 | 97.13% |
| August 31, 2023 | 97.13% |
| July 31, 2023 | 97.13% |
| June 30, 2023 | 97.13% |
| May 31, 2023 | 97.13% |
| April 30, 2023 | 97.13% |
| March 31, 2023 | 97.07% |
| February 28, 2023 | 95.99% |
| January 31, 2023 | 95.99% |
| December 31, 2022 | 95.99% |
| November 30, 2022 | 95.99% |
| October 31, 2022 | 95.99% |
| September 30, 2022 | 96.27% |
| August 31, 2022 | 96.29% |
| Date | Value |
|---|---|
| July 31, 2022 | 96.29% |
| June 30, 2022 | 96.29% |
| May 31, 2022 | 96.29% |
| April 30, 2022 | 96.29% |
| March 31, 2022 | 96.29% |
| February 28, 2022 | 96.29% |
| January 31, 2022 | 96.29% |
| December 31, 2021 | 96.29% |
| November 30, 2021 | 96.29% |
| October 31, 2021 | 96.29% |
| September 30, 2021 | 96.29% |
| August 31, 2021 | 96.29% |
| July 31, 2021 | 96.29% |
| June 30, 2021 | 96.29% |
| May 31, 2021 | 96.29% |
| April 30, 2021 | 96.29% |
| March 31, 2021 | 96.29% |
| February 28, 2021 | 96.29% |
| January 31, 2021 | 98.17% |
| December 31, 2020 | 98.21% |
| November 30, 2020 | 98.50% |
| October 31, 2020 | 98.50% |
| September 30, 2020 | 98.50% |
| August 31, 2020 | 98.50% |
| July 31, 2020 | 98.50% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
95.99%
Minimum
Oct 2022
99.19%
Maximum
Aug 2024
97.33%
Average
97.13%
Median
Apr 2023
Max Drawdown (5Y) Benchmarks
| Moderna Inc | 85.65% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -67.96 |
| Beta (5Y) | 1.496 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 107.3% |
| Historical Sharpe Ratio (5Y) | -0.4432 |
| Historical Sortino (5Y) | -0.8052 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.49% |